XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
Net Parent company investment
Balance, beginning at Dec. 31, 2021 $ 19,925 $ 0 $ 0 $ 0 $ 145 $ 19,780
Balance, beginning of period (in shares) at Dec. 31, 2021   0        
Increase (Decrease) in Stockholders' Equity            
Net loss prior to Business Combination (15,979)         (15,979)
Other comprehensive loss, net of tax (100)       (100)  
Net contribution from H-D 19,051         19,051
Balance, ending at Mar. 27, 2022 22,897 $ 0 0 0 45 22,852
Balance, ending of period (in shares) at Mar. 27, 2022   0        
Balance, beginning at Dec. 31, 2021 19,925 $ 0 0 0 145 19,780
Balance, beginning of period (in shares) at Dec. 31, 2021   0        
Increase (Decrease) in Stockholders' Equity            
Net loss prior to Business Combination (35,557)          
Balance, ending at Jun. 26, 2022 37,385 $ 0 0 0 51 37,334
Balance, ending of period (in shares) at Jun. 26, 2022   0        
Balance, beginning at Mar. 27, 2022 22,897 $ 0 0 0 45 22,852
Balance, beginning of period (in shares) at Mar. 27, 2022   0        
Increase (Decrease) in Stockholders' Equity            
Net loss prior to Business Combination (19,578)         (19,578)
Other comprehensive loss, net of tax 6       6  
Net contribution from H-D 34,060         34,060
Balance, ending at Jun. 26, 2022 37,385 $ 0 0 0 51 37,334
Balance, ending of period (in shares) at Jun. 26, 2022   0        
Balance, beginning at Dec. 31, 2022 $ 306,800 $ 20 329,218 (22,438) 0 0
Balance, beginning of period (in shares) at Dec. 31, 2022 202,403 202,403        
Increase (Decrease) in Stockholders' Equity            
Net loss prior to Business Combination $ (21,147)     (21,147)    
Share-based compensation expense 1,824   1,824      
Share-based compensation expense (in shares)   6        
Balance, ending at Mar. 31, 2023 287,477 $ 20 331,042 (43,585) 0 0
Balance, ending of period (in shares) at Mar. 31, 2023   202,409        
Balance, beginning at Dec. 31, 2022 $ 306,800 $ 20 329,218 (22,438) 0 0
Balance, beginning of period (in shares) at Dec. 31, 2022 202,403 202,403        
Increase (Decrease) in Stockholders' Equity            
Net loss prior to Business Combination $ (61,879)          
Balance, ending at Jun. 30, 2023 $ 249,129 $ 20 333,426 (84,317) 0 0
Balance, ending of period (in shares) at Jun. 30, 2023 202,409 202,409        
Balance, beginning at Mar. 31, 2023 $ 287,477 $ 20 331,042 (43,585) 0 0
Balance, beginning of period (in shares) at Mar. 31, 2023   202,409        
Increase (Decrease) in Stockholders' Equity            
Net loss prior to Business Combination (40,732)     (40,732)    
Share-based compensation expense 2,378   2,378      
Shareholder warrants exercised 6   6      
Balance, ending at Jun. 30, 2023 $ 249,129 $ 20 $ 333,426 $ (84,317) $ 0 $ 0
Balance, ending of period (in shares) at Jun. 30, 2023 202,409 202,409